BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 10352036)

  • 21. Coexpression of alpha and beta subunits of the rod cyclic GMP-gated channel restores native sensitivity to cyclic AMP: role of D604/N1201.
    Pagès F; Ildefonse M; Ragno M; Crouzy S; Bennett N
    Biophys J; 2000 Mar; 78(3):1227-39. PubMed ID: 10692312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Control of ligand specificity in cyclic nucleotide-gated channels from rod photoreceptors and olfactory epithelium.
    Altenhofen W; Ludwig J; Eismann E; Kraus W; Bönigk W; Kaupp UB
    Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9868-72. PubMed ID: 1719541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gating of cyclic nucleotide-gated (CNGA1) channels by cGMP jumps and depolarizing voltage steps.
    Nache V; Kusch J; Hagen V; Benndorf K
    Biophys J; 2006 May; 90(9):3146-54. PubMed ID: 16473910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Movement of the C-helix during the gating of cyclic nucleotide-gated channels.
    Mazzolini M; Punta M; Torre V
    Biophys J; 2002 Dec; 83(6):3283-95. PubMed ID: 12496096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific labeling and permanent activation of the retinal rod cGMP-activated channel by the photoaffinity analog 8-p-azidophenacylthio-cGMP.
    Brown RL; Gerber WV; Karpen JW
    Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5369-73. PubMed ID: 7685123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of inhibition of cyclic nucleotide-gated channel by protein tyrosine kinase probed with genistein.
    Molokanova E; Kramer RH
    J Gen Physiol; 2001 Mar; 117(3):219-34. PubMed ID: 11222626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of tetracaine block of cyclic nucleotide-gated channels.
    Fodor AA; Gordon SE; Zagotta WN
    J Gen Physiol; 1997 Jan; 109(1):3-14. PubMed ID: 8997661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure and rearrangements in the carboxy-terminal region of SpIH channels.
    Flynn GE; Black KD; Islas LD; Sankaran B; Zagotta WN
    Structure; 2007 Jun; 15(6):671-82. PubMed ID: 17562314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interactions of cyclic nucleotide-gated channel subunits and protein tyrosine kinase probed with genistein.
    Molokanova E; Savchenko A; Kramer RH
    J Gen Physiol; 2000 Jun; 115(6):685-96. PubMed ID: 10828243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Localization of regions affecting an allosteric transition in cyclic nucleotide-activated channels.
    Gordon SE; Zagotta WN
    Neuron; 1995 Apr; 14(4):857-64. PubMed ID: 7536427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stoichiometry and arrangement of subunits in rod cyclic nucleotide-gated channels.
    Shammat IM; Gordon SE
    Neuron; 1999 Aug; 23(4):809-19. PubMed ID: 10482246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interdependence of receptor activation and ligand binding in HCN2 pacemaker channels.
    Kusch J; Biskup C; Thon S; Schulz E; Nache V; Zimmer T; Schwede F; Benndorf K
    Neuron; 2010 Jul; 67(1):75-85. PubMed ID: 20624593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation and characterization of the alpha-subunit of the rat rod photoreceptor cGMP-gated cation channel.
    Barnstable CJ; Wei J-Y
    J Mol Neurosci; 1995; 6(4):289-302. PubMed ID: 8860239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A state-independent interaction between ligand and a conserved arginine residue in cyclic nucleotide-gated channels reveals a functional polarity of the cyclic nucleotide binding site.
    Tibbs GR; Liu DT; Leypold BG; Siegelbaum SA
    J Biol Chem; 1998 Feb; 273(8):4497-505. PubMed ID: 9468504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Covalent tethering of ligands to retinal rod cyclic nucleotide-gated channels: binding site structure and allosteric mechanism.
    Karpen JW; Ruiz M; Brown RL
    Methods Enzymol; 2000; 315():755-72. PubMed ID: 10736739
    [No Abstract]   [Full Text] [Related]  

  • 36. Relating ligand binding to activation gating in CNGA2 channels.
    Biskup C; Kusch J; Schulz E; Nache V; Schwede F; Lehmann F; Hagen V; Benndorf K
    Nature; 2007 Mar; 446(7134):440-3. PubMed ID: 17322905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct structural determinants of efficacy and sensitivity in the ligand-binding domain of cyclic nucleotide-gated channels.
    Young EC; Krougliak N
    J Biol Chem; 2004 Jan; 279(5):3553-62. PubMed ID: 14594805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism of calcium/calmodulin inhibition of rod cyclic nucleotide-gated channels.
    Trudeau MC; Zagotta WN
    Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8424-9. PubMed ID: 12048242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allosteric activation and tuning of ligand efficacy in cyclic-nucleotide-gated channels.
    Tibbs GR; Goulding EH; Siegelbaum SA
    Nature; 1997 Apr; 386(6625):612-5. PubMed ID: 9121585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gating of HCN channels by cyclic nucleotides: residue contacts that underlie ligand binding, selectivity, and efficacy.
    Zhou L; Siegelbaum SA
    Structure; 2007 Jun; 15(6):655-70. PubMed ID: 17562313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.